News & Updates
Filter by Specialty:
What prevents patients from receiving a COVID-19 vaccine?
A recent study has found potential associations between vaccine hesitancy and epidemiologic factors, including barriers to receiving vaccination against COVID-19.
What prevents patients from receiving a COVID-19 vaccine?
18 Dec 2023
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
Baricitinib, ivermectin, and favipiravir stood out in terms of efficacy in a network meta-analysis evaluating various novel oral antivirals for the treatment of COVID-19.
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
15 Dec 2023
BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis
In the treatment of patients with rifampicin-resistant tuberculosis, a 6-month oral regimen consisting of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) is safe and efficacious and compares favourably with standard of care, as shown in the final data from the phase IIB-III TB-PRACTECAL study.
BPaLM regimen continues to show benefit against rifampicin-resistant tuberculosis
12 Dec 2023
One in six CYPs in SG develop long COVID
In Singapore, about one in six children and young persons (CYPs) developed long COVID, with persistence of ≥1 symptoms 3 months after an acute COVID-19 infection, a survey study suggests.
One in six CYPs in SG develop long COVID
11 Dec 2023
Empagliflozin of little benefit in patients hospitalized for COVID-19
In patients who are hospitalized for COVID-19, treatment with empagliflozin does not appear to have any positive impact on outcomes such as 28-day mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or death, as shown in the open-label RECOVERY trial.